Global Preimplantation Genetic Testing Market Growth (Status and Outlook) 2024-2030

Global Preimplantation Genetic Testing Market Growth (Status and Outlook) 2024-2030

According to our LPI (LP Information) latest study, the global Preimplantation Genetic Testing market size was valued at US$ 338.6 million in 2023. With growing demand in downstream market, the Preimplantation Genetic Testing is forecast to a readjusted size of US$ 509.6 million by 2030 with a CAGR of 6.0% during review period.

The research report highlights the growth potential of the global Preimplantation Genetic Testing market. Preimplantation Genetic Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Preimplantation Genetic Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Preimplantation Genetic Testing market.

Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality. In contrast, preimplantation genetic screening (PGS) refers to techniques where embryos from presumed chromosomally normal genetic parents are screened for aneuploidy.

North America accounted for the largest share of the global preimplantation genetic testing market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions.

Key Features:

The report on Preimplantation Genetic Testing market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Preimplantation Genetic Testing market. It may include historical data, market segmentation by Type (e.g., Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Preimplantation Genetic Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Preimplantation Genetic Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Preimplantation Genetic Testing industry. This include advancements in Preimplantation Genetic Testing technology, Preimplantation Genetic Testing new entrants, Preimplantation Genetic Testing new investment, and other innovations that are shaping the future of Preimplantation Genetic Testing.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Preimplantation Genetic Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Preimplantation Genetic Testing product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Preimplantation Genetic Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Preimplantation Genetic Testing market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Preimplantation Genetic Testing market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Preimplantation Genetic Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Preimplantation Genetic Testing market.

Market Segmentation:

Preimplantation Genetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Segmentation by application
Maternity Centers & Fertility Clinics
Hospitals, Diagnostic Labs, and Service Providers
Research Laboratories & Academic Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher
Agilent Technologies
Perkinelmer
Coopersurgical
Abbott Laboratories
Natera
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute
Good Start Genetics
Invicta Genetics
Combimatrix
Genea Limited
Progenesis

Please note: The report will take approximately 2 business days to prepare and deliver.